Nitrosamine Contamination in Generics: Recent Cases and Regulatory Response
Martyn F. Feb. 7 12Nitrosamine contamination in generic drugs has triggered hundreds of recalls since 2018, exposing hidden cancer risks in everyday medications. The FDA's response has reshaped global drug safety standards - and forced manufacturers to rethink how medicines are made.
More Detail
Nitrosamine Contamination in Generics: Recent Cases and Regulatory Response
Martyn F. Feb. 7 13Since 2018, nitrosamine contamination has triggered hundreds of recalls in generic drugs like valsartan, metformin, and Zantac. Learn how these carcinogenic impurities form, why regulators changed their rules, and what it means for patients and manufacturers.
More Detail
Real-World Evidence Sources for Drug Safety: Registries and Claims Data Explained
Martyn F. Feb. 5 13How registries and claims data help monitor drug safety after approval. Learn about FDA's use of these sources, their strengths and limitations, and current innovations in drug safety monitoring.
More Detail
Diabetic Kidney Disease: How Early Albuminuria Signals Risk and Why Tight Control Saves Kidneys
Early albuminuria is the first sign of diabetic kidney disease. Tight blood sugar and blood pressure control, plus new medications like SGLT2 inhibitors and finerenone, can prevent kidney failure. Annual UACR testing saves lives.
Opioid Withdrawal: How to Safely Taper and Manage Symptoms
Learn how to safely taper off opioids with evidence-based strategies to manage withdrawal symptoms, avoid relapse, and improve long-term well-being. Based on CDC 2022 guidelines and real patient experiences.
How a Transient Ischemic Attack Can Trigger Vision Problems - Signs, Risks & Action Plan
Learn how a transient ischemic attack can cause sudden vision loss, the warning signs to watch for, underlying vascular causes, and steps to act fast and prevent a stroke.